Related Experiment Video
Updated: May 6, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review
Nele A J De Witte1, Cleo L Crunelle, Bernard Sabbe
1Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium.
Aims:
This review provides evidence of which interventions need to be part of effective outpatient integrated treatment for patients with comorbid schizophrenia and substance use disorders.
Methods:
A total of 14 randomized controlled trials were included. Effect sizes are provided to assess the magnitude of the treatments' efficacy.
Results:
Despite the studies' heterogeneity, we can conclude that certain programs (e.g. Behavioral Treatment for Substance Abuse in Severe and Persistent Mental Illness ) and specific interventions (e.g. motivational interviewing, family interventions) seem to be effective. Moreover, programs integrating multiple interventions are more likely to be positively related to better outcomes than single interventions. Finally, the lack of difference between effect sizes of assertive community treatment compared to case management suggests that a lower caseload is not necessary for positive treatment outcomes.
Conclusion:
Integrated treatment seems advantageous, although effect sizes are mostly modest. More homogeneous and qualitative sound studies are needed.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Psychological and Sociocultural Causes of Schizophrenia
Antidepressant Drugs: MAOIs and Other Agents

